Clinical Trials Directory

Trials / Conditions / Metastatic Esophageal Cancer

Metastatic Esophageal Cancer

7 registered clinical trials studyying Metastatic Esophageal Cancer — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People Wit
NCT06251973
Memorial Sloan Kettering Cancer CenterPhase 2
SuspendedNatural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbet
NCT05400122
David WaldPhase 1
Active Not RecruitingWaKING: Wnt and checKpoint INhibition in Gastric Cancer
NCT04166721
Royal Marsden NHS Foundation TrustPhase 1 / Phase 2
CompletedCombination of Cryosurgery and NK Immunotherapy for Advanced Esophageal Cancer
NCT02843581
Fuda Cancer Hospital, GuangzhouPhase 1 / Phase 2
UnknownSBRT Combined With Thymalfasin for Metastatic Esophageal Cancer
NCT02545751
Hangzhou Cancer HospitalPhase 2
UnknownApatinib for Metastatic Esophageal Cancer.
NCT02544737
Hangzhou Cancer HospitalPhase 2
CompletedPhase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric
NCT01715233
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2